Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200077015> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4200077015 endingPage "S715" @default.
- W4200077015 startingPage "S715" @default.
- W4200077015 abstract "Abstract Background Taniborbactam (formerly VNRX-5133) is a novel cyclic boronate-based broad-spectrum β-lactamase inhibitor with potent and selective direct inhibitory activity against both serine- and metallo-β-lactamases (Ambler Classes A, B, C and D). Taniborbactam restores the activity of cefepime against many difficult to treat organisms, including cephalosporin- and carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa. The activity of the investigational combination cefepime-taniborbactam (FTB) and comparator agents was evaluated against clinical isolates of Enterobacterales from a 2018-2020 global surveillance study. Methods MICs of cefepime with taniborbactam fixed at 4 µg/mL and comparators were determined following CLSI M07-A11 guidelines against 10,543 Enterobacterales. Isolates were from community and hospital infections collected from 259 sites in 56 countries in 2018-2020. Resistant phenotypes were based on 2021 CLSI breakpoints. A set of 827 isolates with meropenem MIC ≥4 µg/mL (n=421) or with cefepime and/or ceftazidime MIC ≥2 µg/mL (n=406) was evaluated for the presence of MBLs, KPC, ESBLs, and OXA-48 group genes via PCR and sequencing. Forty-eight isolates with FTB MIC values of 16 µg/mL or greater were interrogated by WGS. Results Overall, 23.0% and 15.9% of isolates were nonsusceptible (NS) to cefepime and piperacillin-tazobactam (TZP), respectively (Table). FTB had potent activity against all Enterobacterales, with MIC50/90 values of 0.06/0.25 µg/mL and 99.5% inhibited at ≤8 µg/mL. FTB maintained activity against MBL-, KPC-, OXA-48 group, and ESBL-positive isolates (MIC90 range, 1 to >16 µg/mL; 80.5% to 100% inhibited at ≤8 µg/mL). Isolates with elevated FTB MICs had IMP-type enzymes, variation in the cefepime target (penicillin binding protein 3), permeability defects in combination with acquired β-lactamases, and/or possible up-regulated efflux. Results Table Conclusion Taniborbactam significantly restored the in vitro activity of cefepime against Enterobacterales, including isolates nonsusceptible to recently-approved BL/BLI combinations and expressing serine and metallo-β-lactamases. This support the continued development of FTB as a potential new treatment option for challenging infections due to resistant Gram-negative pathogens. Disclosures Meredith Hackel, PhD MPH, IHMA (Employee)Pfizer, Inc. (Independent Contractor) Mark G G. Wise, PhD, IHMA (Employee)Pfizer, Inc. (Independent Contractor) Daniel F. Sahm, PhD, IHMA (Employee)Pfizer, Inc. (Independent Contractor)" @default.
- W4200077015 created "2021-12-31" @default.
- W4200077015 creator A5020290756 @default.
- W4200077015 creator A5038009031 @default.
- W4200077015 creator A5074302829 @default.
- W4200077015 date "2021-11-01" @default.
- W4200077015 modified "2023-09-25" @default.
- W4200077015 title "1253. Antimicrobial Activity of Cefepime in Combination with Taniborbactam Against Clinical Isolates of Enterobacterales from 2018-2020 Global Surveillance" @default.
- W4200077015 doi "https://doi.org/10.1093/ofid/ofab466.1445" @default.
- W4200077015 hasPublicationYear "2021" @default.
- W4200077015 type Work @default.
- W4200077015 citedByCount "0" @default.
- W4200077015 crossrefType "journal-article" @default.
- W4200077015 hasAuthorship W4200077015A5020290756 @default.
- W4200077015 hasAuthorship W4200077015A5038009031 @default.
- W4200077015 hasAuthorship W4200077015A5074302829 @default.
- W4200077015 hasBestOaLocation W42000770151 @default.
- W4200077015 hasConcept C2776685102 @default.
- W4200077015 hasConcept C2776968632 @default.
- W4200077015 hasConcept C2777050379 @default.
- W4200077015 hasConcept C2777637488 @default.
- W4200077015 hasConcept C2778193466 @default.
- W4200077015 hasConcept C2778266534 @default.
- W4200077015 hasConcept C2779375183 @default.
- W4200077015 hasConcept C2779631663 @default.
- W4200077015 hasConcept C4937899 @default.
- W4200077015 hasConcept C501593827 @default.
- W4200077015 hasConcept C523546767 @default.
- W4200077015 hasConcept C54355233 @default.
- W4200077015 hasConcept C64778159 @default.
- W4200077015 hasConcept C71924100 @default.
- W4200077015 hasConcept C86803240 @default.
- W4200077015 hasConcept C89423630 @default.
- W4200077015 hasConcept C94665300 @default.
- W4200077015 hasConceptScore W4200077015C2776685102 @default.
- W4200077015 hasConceptScore W4200077015C2776968632 @default.
- W4200077015 hasConceptScore W4200077015C2777050379 @default.
- W4200077015 hasConceptScore W4200077015C2777637488 @default.
- W4200077015 hasConceptScore W4200077015C2778193466 @default.
- W4200077015 hasConceptScore W4200077015C2778266534 @default.
- W4200077015 hasConceptScore W4200077015C2779375183 @default.
- W4200077015 hasConceptScore W4200077015C2779631663 @default.
- W4200077015 hasConceptScore W4200077015C4937899 @default.
- W4200077015 hasConceptScore W4200077015C501593827 @default.
- W4200077015 hasConceptScore W4200077015C523546767 @default.
- W4200077015 hasConceptScore W4200077015C54355233 @default.
- W4200077015 hasConceptScore W4200077015C64778159 @default.
- W4200077015 hasConceptScore W4200077015C71924100 @default.
- W4200077015 hasConceptScore W4200077015C86803240 @default.
- W4200077015 hasConceptScore W4200077015C89423630 @default.
- W4200077015 hasConceptScore W4200077015C94665300 @default.
- W4200077015 hasIssue "Supplement_1" @default.
- W4200077015 hasLocation W42000770151 @default.
- W4200077015 hasLocation W42000770152 @default.
- W4200077015 hasOpenAccess W4200077015 @default.
- W4200077015 hasPrimaryLocation W42000770151 @default.
- W4200077015 hasRelatedWork W1999158795 @default.
- W4200077015 hasRelatedWork W2035839741 @default.
- W4200077015 hasRelatedWork W2116303484 @default.
- W4200077015 hasRelatedWork W2132068732 @default.
- W4200077015 hasRelatedWork W2750764083 @default.
- W4200077015 hasRelatedWork W2800457509 @default.
- W4200077015 hasRelatedWork W3137961730 @default.
- W4200077015 hasRelatedWork W4200134076 @default.
- W4200077015 hasRelatedWork W4206752707 @default.
- W4200077015 hasRelatedWork W4242790524 @default.
- W4200077015 hasVolume "8" @default.
- W4200077015 isParatext "false" @default.
- W4200077015 isRetracted "false" @default.
- W4200077015 workType "article" @default.